You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MNPR Sale Disclosure
Starr Christopher M · SEC Form 4 · Filed Oct 5, 2026
Sale
Calculated transaction value
$63.66K
Starr Christopher M Director
MNPR
Monopar Therapeutics
MNPR
Transaction date
Oct 1, 2026
Public filing date
Oct 5, 2026
Filing lag
Filed 4 days later
MNPR daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 799 shares @ $79.67
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001437749-26-032048
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$659.43K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Monopar Therapeutics MNPR | Sale | Oct 1, 2026 | $234.1K |
| Monopar Therapeutics MNPR Current | Sale | Oct 1, 2026 | $63.66K |
| Monopar Therapeutics MNPR | Exercise | Oct 1, 2026 | $0 |
| Monopar Therapeutics MNPR | Sale | Oct 1, 2026 | $361.63K |
| Monopar Therapeutics MNPR | Exercise | Oct 1, 2026 | $42 |